Neuroscience
Receptor Agonists
100%
Gastric Inhibitory Polypeptide Receptor
100%
Tetrahydropyridine
100%
Dopamine
66%
Parkinson's Disease
33%
Homovanillic Acid
16%
Gastric Inhibitory Polypeptide
16%
Catabolism
16%
Parkinsonism
16%
Glutathione
16%
Tremor
16%
Receptor Antagonist
16%
Nigrostriatal Pathway
16%
Akinesia
16%
Phenotype
16%
Locomotor Activity
16%
Cell Signaling
16%
Pharmacology, Toxicology and Pharmaceutical Science
Gastric Inhibitory Polypeptide Receptor
100%
Receptor Agonist
100%
1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine
100%
Dopamine
66%
Parkinson Disease
33%
Malonaldehyde
16%
Receptor Antagonist
16%
MPTP-induced Parkinsonism
16%
Glutathione
16%
3,4 Dihydroxyphenylacetic Acid
16%
Gastric Inhibitory Polypeptide
16%
Akinesia
16%
Homovanillic Acid
16%
Tremor
16%
Muscle Rigidity
16%
Symptom
16%
INIS
receptors
100%
polypeptides
100%
dopamine
66%
psychological behavior
33%
nervous system diseases
33%
phenotype
16%
metabolites
16%
catabolism
16%
glutathione
16%
amplitudes
16%
symptoms
16%
losses
16%